Back
Blueprint Medicines Stock Price Chart
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.
Buy
55
BPMC
Blueprint Medicines
Last Price:
91.37
Seasonality Move:
11.38%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!- The current trend is moderately bullish and BPMC is experiencing slight buying pressure.
Blueprint Medicines Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 91 | Buy |
| 20-day SMA: | 90.38 | Buy |
| 50-day SMA: | 90.76 | Buy |
| 200-day SMA: | 70.52 | Buy |
| 8-day EMA: | 91.4 | Buy |
| 20-day EMA: | 90.62 | Buy |
| 50-day EMA: | 88.95 | Buy |
| 200-day EMA: | 75.53 | Buy |
Blueprint Medicines Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 56.1 | Buy |
| Chaikin Money Flow: | 28536 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.15 - 93.59) | Buy |
| Bollinger Bands (100): | (80.5 - 92.58) | Buy |
Blueprint Medicines Technical Analysis
| Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
- Blueprint Medicines share price is 93.10 while BPMC 8-day simple moving average is 91.00, which is a Buy signal.
- The stock price of BPMC is 93.10 while Blueprint Medicines 20-day SMA is 90.38, which makes it a Buy.
- Blueprint Medicines 50-day simple moving average is 90.76 while BPMC share price is 93.10, making it a Buy technically.
- BPMC stock price is 93.10 and Blueprint Medicines 200-day simple moving average is 70.52, creating a Buy signal.
BPMC Technical Analysis vs Fundamental Analysis
Buy
55
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a Buy
The current Blueprint Medicines [BPMC] share price is $93.10. The Score for BPMC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Blueprint Medicines Stock Info
Market Cap:
5.7B
Price in USD:
93.10
Share Volume:
622.91K
Blueprint Medicines 52-Week Range
52-Week High:
101.00
52-Week Low:
43.89
Buy
55
Blueprint Medicines (BPMC)
is a Buy
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?
The Blueprint Medicines stock price is 93.10 USD today. -
Will BPMC stock go up or go down?
Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators -
Is Blueprint Medicines overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is not overvalued.
Is Blueprint Medicines Stock a Buy?
- Blueprint Medicines share price is 93.10 while BPMC 8-day exponential moving average is 91.40, which is a Buy signal.
- The stock price of BPMC is 93.10 while Blueprint Medicines 20-day EMA is 90.62, which makes it a Buy.
- Blueprint Medicines 50-day exponential moving average is 88.95 while BPMC share price is 93.10, making it a Buy technically.
- BPMC stock price is 93.10 and Blueprint Medicines 200-day simple moving average is 75.53, creating a Buy signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
- Analysts estimate an earnings increase this quarter of $1.00 per share, an increase next quarter of $0.24 per share, an increase this year of $2.91 per share, and an increase next year of $3.17 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
- BPMC Moving Average Covergence Divergence (MACD) indicator is 0.57, suggesting Blueprint Medicines is a Buy
- Blueprint Medicines Relative Strength Index (RSI) is 56.1, which suggest Blueprint Medicines is overbought
- The Bollinger Bands (25) for Blueprint Medicines is (88.15 - 93.59), which suggest Blueprint Medicines is a Buy
- The Bollinger Bands (100) for Blueprint Medicines is (80.5 - 92.58), which suggest Blueprint Medicines is a Buy
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.